[ Price : $8.95]
Johnson & Johnson says its gene therapy botaretigene sparoparvovec missed the primary endpoint in the Phase 3 LUMEOS study that is...[ Price : $8.95]
A new report from IQVIA finds drug spending in 2024 accelerated, with net prices growing at an 11.4% rate last year compared with ...[ Price : $8.95]
Genentech researchers say FDAs Drug Development Tools Qualification program has had a very limited impact on development programs....[ Price : $8.95]
Public health researchers warn about the broader impacts to emerging technologies (e.g., artificial intelligence) in a March court...[ Price : $8.95]
FDA sends ImmunityBio a refusal to file letter for its recent supplemental BLA submission seeking approval for Anktiva plus Bacill...[ Price : $8.95]
Capricor Therapeutics says it has completed an FDA mid-cycle review meeting on a BLA seeking approval for deramiocel and its use i...[ Price : $8.95]
FDA denies a CytoSorbents de novo marketing request for its DrugSorb-ATR antithrombotic removal system, intended for reducing the ...[ Price : $8.95]
FDA clears a GE HealthCare 510(k) for its MR Contour DL, an artificial intelligence model that uses deep learning for organs-at-ri...